APO Research
Talk to an analyst

APO RESEARCH · REPORT

Recombinant Protein Service

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Recombinant Protein Service Market Analysis and Forecast 2026-2032

17 January 2026194 pages

Choose your research edition.

Industry ResearchRecombinant Protein Service Industry Research Report 2026119 pages · $2,950 USDIndustry Growth & TrendsGlobal Recombinant Protein Service Industry Growth and Trends Forecast to 2032103 pages · $3,450 USDMarket StructureGlobal Recombinant Protein Service Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032195 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Recombinant Protein Service Market Outlook and Growth Opportunities 2026192 pages · $4,250 USDMarket Analysis & ForecastGlobal Recombinant Protein Service Market Analysis and Forecast 2026-2032194 pages · $4,950 USD

Market perspective

The global Recombinant Protein Service market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for Recombinant Protein Service is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Recombinant Protein Service is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Recombinant Protein Service is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Recombinant Protein Service is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of Recombinant Protein Service include Sino Biological, Boster Bio, Proteos, ImmunoDiagnostics Limited, BiologicsCorp, GenScript, OriGene Technologies, R＆D Systems and Biomiga, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Recombinant Protein Service, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Recombinant Protein Service, also provides the revenue of main regions and countries. Of the upcoming market potential for Recombinant Protein Service, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Recombinant Protein Service revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Recombinant Protein Service market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Recombinant Protein Service revenue, projected growth trends, production technology, application and end-user industry.

Recombinant Protein Service Segment by Company

Sino Biological

Boster Bio

Proteos

ImmunoDiagnostics Limited

BiologicsCorp

GenScript

OriGene Technologies

R＆D Systems

Biomiga

Genemed

RayBiotech

BioServUK

Elabscienc

Jubilant Biosys

Recombinant Protein Service Segment by Type

Protein Purification

Protein Expression

Protein Modification And Processing

Other

Recombinant Protein Service Segment by Application

Antibody Production

Vaccine Production

Protein Pharmaceutical Production

Other

Recombinant Protein Service Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Recombinant Protein Service market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Recombinant Protein Service and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Recombinant Protein Service.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Recombinant Protein Service in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Recombinant Protein Service company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Recombinant Protein Service revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Recombinant Protein Service Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Protein Purification Major Player Table 3. Protein Expression Major Player Table 4. Protein Modification And Processing Major Player Table 5. Other Major Player Table 6. Global Recombinant Protein Service Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 7. Antibody Production Major Player Table 8. Vaccine Production Major Player Table 9. Protein Pharmaceutical Production Major Player Table 10. Other Major Player Table 11. Recombinant Protein Service Industry Trends Table 12. Recombinant Protein Service Industry Drivers Table 13. Recombinant Protein Service Industry Opportunities and Challenges Table 14. Recombinant Protein Service Industry Restraints Table 15. Global Recombinant Protein Service Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 16. Global Recombinant Protein Service Market Size by Region (2021-2026) & (US$ Million) Table 17. Global Recombinant Protein Service Market Share by Region (2021-2026) Table 18. Global Recombinant Protein Service Market Size by Region (2027-2032) & (US$ Million) Table 19. Global Recombinant Protein Service Market Share by Region (2027-2032) Table 20. Global Recombinant Protein Service Revenue by Players (US$ Million) & (2021-2026) Table 21. Global Recombinant Protein Service Revenue Market Share by Players (2021-2026) Table 22. Global Recombinant Protein Service Key Players Ranking, 2024 VS 2025 VS 2026 Table 23. Global Recombinant Protein Service Key Players Headquarters & Area Served Table 24. Global Recombinant Protein Service Players, Product Type & Application Table 25. Global Recombinant Protein Service Players Establishment Date Table 26. Global Players Market Concentration Ratio (CR5 and HHI) Table 27. Global Recombinant Protein Service by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 28. Global Recombinant Protein Service Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 29. Global Recombinant Protein Service Revenue by Type (2021-2026) & (US$ Million) Table 30. Global Recombinant Protein Service Revenue by Type (2027-2032) & (US$ Million) Table 31. Global Recombinant Protein Service Revenue Market Share by Type (2021-2026) Table 32. Global Recombinant Protein Service Revenue Market Share by Type (2027-2032) Table 33. Global Recombinant Protein Service Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 34. Global Recombinant Protein Service Revenue by Application (2021-2026) & (US$ Million) Table 35. Global Recombinant Protein Service Revenue by Application (2027-2032) & (US$ Million) Table 36. Global Recombinant Protein Service Revenue Market Share by Application (2021-2026) Table 37. Global Recombinant Protein Service Revenue Market Share by Application (2027-2032) Table 38. Sino Biological Company Information Table 39. Sino Biological Business Overview Table 40. Sino Biological Recombinant Protein Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 41. Sino Biological Recombinant Protein Service Product Portfolio Table 42. Sino Biological Recent Development Table 43. Boster Bio Company Information Table 44. Boster Bio Business Overview Table 45. Boster Bio Recombinant Protein Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 46. Boster Bio Recombinant Protein Service Product Portfolio Table 47. Boster Bio Recent Development Table 48. Proteos Company Information Table 49. Proteos Business Overview Table 50. Proteos Recombinant Protein Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 51. Proteos Recombinant Protein Service Product Portfolio Table 52. Proteos Recent Development Table 53. ImmunoDiagnostics Limited Company Information Table 54. ImmunoDiagnostics Limited Business Overview Table 55. ImmunoDiagnostics Limited Recombinant Protein Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 56. ImmunoDiagnostics Limited Recombinant Protein Service Product Portfolio Table 57. ImmunoDiagnostics Limited Recent Development Table 58. BiologicsCorp Company Information Table 59. BiologicsCorp Business Overview Table 60. BiologicsCorp Recombinant Protein Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 61. BiologicsCorp Recombinant Protein Service Product Portfolio Table 62. BiologicsCorp Recent Development Table 63. GenScript Company Information Table 64. GenScript Business Overview Table 65. GenScript Recombinant Protein Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 66. GenScript Recombinant Protein Service Product Portfolio Table 67. GenScript Recent Development Table 68. OriGene Technologies Company Information Table 69. OriGene Technologies Business Overview Table 70. OriGene Technologies Recombinant Protein Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 71. OriGene Technologies Recombinant Protein Service Product Portfolio Table 72. OriGene Technologies Recent Development Table 73. R＆D Systems Company Information Table 74. R＆D Systems Business Overview Table 75. R＆D Systems Recombinant Protein Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 76. R＆D Systems Recombinant Protein Service Product Portfolio Table 77. R＆D Systems Recent Development Table 78. Biomiga Company Information Table 79. Biomiga Business Overview Table 80. Biomiga Recombinant Protein Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 81. Biomiga Recombinant Protein Service Product Portfolio Table 82. Biomiga Recent Development Table 83. Genemed Company Information Table 84. Genemed Business Overview Table 85. Genemed Recombinant Protein Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 86. Genemed Recombinant Protein Service Product Portfolio Table 87. Genemed Recent Development Table 88. RayBiotech Company Information Table 89. RayBiotech Business Overview Table 90. RayBiotech Recombinant Protein Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 91. RayBiotech Recombinant Protein Service Product Portfolio Table 92. RayBiotech Recent Development Table 93. BioServUK Company Information Table 94. BioServUK Business Overview Table 95. BioServUK Recombinant Protein Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 96. BioServUK Recombinant Protein Service Product Portfolio Table 97. BioServUK Recent Development Table 98. Elabscienc Company Information Table 99. Elabscienc Business Overview Table 100. Elabscienc Recombinant Protein Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 101. Elabscienc Recombinant Protein Service Product Portfolio Table 102. Elabscienc Recent Development Table 103. Jubilant Biosys Company Information Table 104. Jubilant Biosys Business Overview Table 105. Jubilant Biosys Recombinant Protein Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 106. Jubilant Biosys Recombinant Protein Service Product Portfolio Table 107. Jubilant Biosys Recent Development Table 108. North America Recombinant Protein Service Revenue by Type (2021-2026) & (US$ Million) Table 109. North America Recombinant Protein Service Revenue by Type (2027-2032) & (US$ Million) Table 110. North America Recombinant Protein Service Revenue by Application (2021-2026) & (US$ Million) Table 111. North America Recombinant Protein Service Revenue by Application (2027-2032) & (US$ Million) Table 112. North America Recombinant Protein Service Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 113. North America Recombinant Protein Service Revenue by Country (2021-2026) & (US$ Million) Table 114. North America Recombinant Protein Service Revenue by Country (US$ Million) & (2027-2032) Table 115. Europe Recombinant Protein Service Revenue by Type (2021-2026) & (US$ Million) Table 116. Europe Recombinant Protein Service Revenue by Type (2027-2032) & (US$ Million) Table 117. Europe Recombinant Protein Service Revenue by Application (2021-2026) & (US$ Million) Table 118. Europe Recombinant Protein Service Revenue by Application (2027-2032) & (US$ Million) Table 119. Europe Recombinant Protein Service Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 120. Europe Recombinant Protein Service Revenue by Country (2021-2026) & (US$ Million) Table 121. Europe Recombinant Protein Service Revenue by Country (US$ Million) & (2027-2032) Table 122. China Recombinant Protein Service Revenue by Type (2021-2026) & (US$ Million) Table 123. China Recombinant Protein Service Revenue by Type (2027-2032) & (US$ Million) Table 124. China Recombinant Protein Service Revenue by Application (2021-2026) & (US$ Million) Table 125. China Recombinant Protein Service Revenue by Application (2027-2032) & (US$ Million) Table 126. Asia Recombinant Protein Service Revenue by Type (2021-2026) & (US$ Million) Table 127. Asia Recombinant Protein Service Revenue by Type (2027-2032) & (US$ Million) Table 128. Asia Recombinant Protein Service Revenue by Application (2021-2026) & (US$ Million) Table 129. Asia Recombinant Protein Service Revenue by Application (2027-2032) & (US$ Million) Table 130. Asia Recombinant Protein Service Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 131. Asia Recombinant Protein Service Revenue by Region (US$ Million) & (2021-2026) Table 132. Asia Recombinant Protein Service Revenue by Region (US$ Million) & (2027-2032) Table 133. SAMEA Recombinant Protein Service Revenue by Type (2021-2026) & (US$ Million) Table 134. SAMEA Recombinant Protein Service Revenue by Type (2027-2032) & (US$ Million) Table 135. SAMEA Recombinant Protein Service Revenue by Application (2021-2026) & (US$ Million) Table 136. SAMEA Recombinant Protein Service Revenue by Application (2027-2032) & (US$ Million) Table 137. SAMEA Recombinant Protein Service Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 138. SAMEA Recombinant Protein Service Revenue by Country (2021-2026) & (US$ Million) Table 139. SAMEA Recombinant Protein Service Revenue by Country (US$ Million) & (2027-2032) Table 140. Research Programs/Design for This Report Table 141. Authors List of This Report Table 142. Secondary Sources Table 143. Primary Sources List of Figures Figure 1. Recombinant Protein Service Image Figure 2. Global Recombinant Protein Service Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Recombinant Protein Service Market Size Share 2021 VS 2025 VS 2032 Figure 4. Protein Purification Image Figure 5. Protein Expression Image Figure 6. Protein Modification And Processing Image Figure 7. Other Image Figure 8. Global Recombinant Protein Service Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 9. Global Recombinant Protein Service Market Size Share 2021 VS 2025 VS 2032 Figure 10. Antibody Production Image Figure 11. Vaccine Production Image Figure 12. Protein Pharmaceutical Production Image Figure 13. Other Image Figure 14. Global Recombinant Protein Service Market Size (US$ Million) & (2021-2032) Figure 15. Global Recombinant Protein Service Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 16. Global Recombinant Protein Service Market Share by Region: 2021 VS 2025 VS 2032 Figure 17. Global Recombinant Protein Service Players Revenue Share Top 10 and Top 5 in 2025 Figure 18. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 19. Global Recombinant Protein Service Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 20. Global Recombinant Protein Service Revenue Market Share 2021 VS 2025 VS 2032 Figure 21. Global Recombinant Protein Service Revenue Market Share by Type (2021-2032) Figure 22. Global Recombinant Protein Service Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 23. Global Recombinant Protein Service Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 24. Global Recombinant Protein Service Revenue Market Share by Application (2021-2032) Figure 25. North America Recombinant Protein Service Revenue YoY Growth (2021-2032) & (US$ Million) Figure 26. North America Recombinant Protein Service Revenue Share by Type (2021-2032) Figure 27. North America Recombinant Protein Service Revenue Share by Application (2021-2032) Figure 28. North America Recombinant Protein Service Revenue Share by Country (2021-2032) Figure 29. United States Recombinant Protein Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 30. Canada Recombinant Protein Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 31. Mexico Recombinant Protein Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 32. Europe Recombinant Protein Service Revenue YoY Growth (2021-2032) & (US$ Million) Figure 33. Europe Recombinant Protein Service Revenue Share by Type (2021-2032) Figure 34. Europe Recombinant Protein Service Revenue Share by Application (2021-2032) Figure 35. Europe Recombinant Protein Service Revenue Share by Country (2021-2032) Figure 36. Germany Recombinant Protein Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. France Recombinant Protein Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. U.K. Recombinant Protein Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Italy Recombinant Protein Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Spain Recombinant Protein Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. Russia Recombinant Protein Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 42. Netherlands Recombinant Protein Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 43. Nordic Countries Recombinant Protein Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 44. China Recombinant Protein Service Revenue YoY Growth (2021-2032) & (US$ Million) Figure 45. China Recombinant Protein Service Revenue Share by Type (2021-2032) Figure 46. China Recombinant Protein Service Revenue Share by Application (2021-2032) Figure 47. Asia Recombinant Protein Service Revenue YoY Growth (2021-2032) & (US$ Million) Figure 48. Asia Recombinant Protein Service Revenue Share by Type (2021-2032) Figure 49. Asia Recombinant Protein Service Revenue Share by Application (2021-2032) Figure 50. Asia Recombinant Protein Service Revenue Share by Region (2021-2032) Figure 51. Japan Recombinant Protein Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. South Korea Recombinant Protein Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. India Recombinant Protein Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. Australia Recombinant Protein Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 55. Taiwan Recombinant Protein Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 56. Southeast Asia Recombinant Protein Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 57. SAMEA Recombinant Protein Service Revenue YoY Growth (2021-2032) & (US$ Million) Figure 58. SAMEA Recombinant Protein Service Revenue Share by Type (2021-2032) Figure 59. SAMEA Recombinant Protein Service Revenue Share by Application (2021-2032) Figure 60. SAMEA Recombinant Protein Service Revenue Share by Country (2021-2032) Figure 61. Brazil Recombinant Protein Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Argentina Recombinant Protein Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Chile Recombinant Protein Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Colombia Recombinant Protein Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. Peru Recombinant Protein Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. Saudi Arabia Recombinant Protein Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Israel Recombinant Protein Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. UAE Recombinant Protein Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Turkey Recombinant Protein Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 70. Iran Recombinant Protein Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 71. Egypt Recombinant Protein Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 72. Years Considered Figure 73. Research Process Figure 74. Key Executives Interviewed

Scope & coverage.

Types
  • Protein Purification
  • Protein Expression
  • Protein Modification And Processing
  • Other
Applications
  • Antibody Production
  • Vaccine Production
  • Protein Pharmaceutical Production
  • Other
Companies covered
  • Sino Biological
  • Boster Bio
  • Proteos
  • ImmunoDiagnostics Limited
  • BiologicsCorp
  • GenScript
  • OriGene Technologies
  • R＆D Systems
  • Biomiga
  • Genemed
  • RayBiotech
  • BioServUK
  • Elabscienc
  • Jubilant Biosys

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Recombinant Protein Service Market by Type
  3. 1.2.1 Global Recombinant Protein Service Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Protein Purification
  5. 1.2.3 Protein Expression
  6. 1.2.4 Protein Modification And Processing
  7. 1.2.5 Other
  8. 1.3 Recombinant Protein Service Market by Application
  9. 1.3.1 Global Recombinant Protein Service Market Size by Application, 2021 VS 2025 VS 2032
  10. 1.3.2 Antibody Production
  11. 1.3.3 Vaccine Production
  12. 1.3.4 Protein Pharmaceutical Production
  13. 1.3.5 Other
  14. 1.4 Assumptions and Limitations
  15. 1.5 Study Goals and Objectives
2 Recombinant Protein Service Market Dynamics
  1. 2.1 Recombinant Protein Service Industry Trends
  2. 2.2 Recombinant Protein Service Industry Drivers
  3. 2.3 Recombinant Protein Service Industry Opportunities and Challenges
  4. 2.4 Recombinant Protein Service Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Recombinant Protein Service Market Perspective (2021-2032)
  2. 3.2 Global Recombinant Protein Service Growth Trends by Region
  3. 3.2.1 Global Recombinant Protein Service Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Recombinant Protein Service Market Size by Region (2021-2026)
  5. 3.2.3 Global Recombinant Protein Service Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Recombinant Protein Service Revenue by Players
  2. 4.1.1 Global Recombinant Protein Service Revenue by Players (2021-2026)
  3. 4.1.2 Global Recombinant Protein Service Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Recombinant Protein Service Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Recombinant Protein Service Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Recombinant Protein Service Key Players Headquarters & Area Served
  7. 4.4 Global Recombinant Protein Service Players, Product Type & Application
  8. 4.5 Global Recombinant Protein Service Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Recombinant Protein Service Market CR5 and HHI
  11. 4.6.3 2025 Recombinant Protein Service Tier 1, Tier 2, and Tier 3
5 Recombinant Protein Service Market Size by Type
  1. 5.1 Global Recombinant Protein Service Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Recombinant Protein Service Revenue by Type (2021-2032)
  3. 5.3 Global Recombinant Protein Service Revenue Market Share by Type (2021-2032)
6 Recombinant Protein Service Market Size by Application
  1. 6.1 Global Recombinant Protein Service Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Recombinant Protein Service Revenue by Application (2021-2032)
  3. 6.3 Global Recombinant Protein Service Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 Sino Biological
  2. 7.1.1 Sino Biological Company Information
  3. 7.1.2 Sino Biological Business Overview
  4. 7.1.3 Sino Biological Recombinant Protein Service Revenue and Gross Margin (2021-2026)
  5. 7.1.4 Sino Biological Recombinant Protein Service Product Portfolio
  6. 7.1.5 Sino Biological Recent Developments
  7. 7.2 Boster Bio
  8. 7.2.1 Boster Bio Company Information
  9. 7.2.2 Boster Bio Business Overview
  10. 7.2.3 Boster Bio Recombinant Protein Service Revenue and Gross Margin (2021-2026)
  11. 7.2.4 Boster Bio Recombinant Protein Service Product Portfolio
  12. 7.2.5 Boster Bio Recent Developments
  13. 7.3 Proteos
  14. 7.3.1 Proteos Company Information
  15. 7.3.2 Proteos Business Overview
  16. 7.3.3 Proteos Recombinant Protein Service Revenue and Gross Margin (2021-2026)
  17. 7.3.4 Proteos Recombinant Protein Service Product Portfolio
  18. 7.3.5 Proteos Recent Developments
  19. 7.4 ImmunoDiagnostics Limited
  20. 7.4.1 ImmunoDiagnostics Limited Company Information
  21. 7.4.2 ImmunoDiagnostics Limited Business Overview
  22. 7.4.3 ImmunoDiagnostics Limited Recombinant Protein Service Revenue and Gross Margin (2021-2026)
  23. 7.4.4 ImmunoDiagnostics Limited Recombinant Protein Service Product Portfolio
  24. 7.4.5 ImmunoDiagnostics Limited Recent Developments
  25. 7.5 BiologicsCorp
  26. 7.5.1 BiologicsCorp Company Information
  27. 7.5.2 BiologicsCorp Business Overview
  28. 7.5.3 BiologicsCorp Recombinant Protein Service Revenue and Gross Margin (2021-2026)
  29. 7.5.4 BiologicsCorp Recombinant Protein Service Product Portfolio
  30. 7.5.5 BiologicsCorp Recent Developments
  31. 7.6 GenScript
  32. 7.6.1 GenScript Company Information
  33. 7.6.2 GenScript Business Overview
  34. 7.6.3 GenScript Recombinant Protein Service Revenue and Gross Margin (2021-2026)
  35. 7.6.4 GenScript Recombinant Protein Service Product Portfolio
  36. 7.6.5 GenScript Recent Developments
  37. 7.7 OriGene Technologies
  38. 7.7.1 OriGene Technologies Company Information
  39. 7.7.2 OriGene Technologies Business Overview
  40. 7.7.3 OriGene Technologies Recombinant Protein Service Revenue and Gross Margin (2021-2026)
  41. 7.7.4 OriGene Technologies Recombinant Protein Service Product Portfolio
  42. 7.7.5 OriGene Technologies Recent Developments
  43. 7.8 R＆D Systems
  44. 7.8.1 R＆D Systems Company Information
  45. 7.8.2 R＆D Systems Business Overview
  46. 7.8.3 R＆D Systems Recombinant Protein Service Revenue and Gross Margin (2021-2026)
  47. 7.8.4 R＆D Systems Recombinant Protein Service Product Portfolio
  48. 7.8.5 R＆D Systems Recent Developments
  49. 7.9 Biomiga
  50. 7.9.1 Biomiga Company Information
  51. 7.9.2 Biomiga Business Overview
  52. 7.9.3 Biomiga Recombinant Protein Service Revenue and Gross Margin (2021-2026)
  53. 7.9.4 Biomiga Recombinant Protein Service Product Portfolio
  54. 7.9.5 Biomiga Recent Developments
  55. 7.10 Genemed
  56. 7.10.1 Genemed Company Information
  57. 7.10.2 Genemed Business Overview
  58. 7.10.3 Genemed Recombinant Protein Service Revenue and Gross Margin (2021-2026)
  59. 7.10.4 Genemed Recombinant Protein Service Product Portfolio
  60. 7.10.5 Genemed Recent Developments
  61. 7.11 RayBiotech
  62. 7.11.1 RayBiotech Company Information
  63. 7.11.2 RayBiotech Business Overview
  64. 7.11.3 RayBiotech Recombinant Protein Service Revenue and Gross Margin (2021-2026)
  65. 7.11.4 RayBiotech Recombinant Protein Service Product Portfolio
  66. 7.11.5 RayBiotech Recent Developments
  67. 7.12 BioServUK
  68. 7.12.1 BioServUK Company Information
  69. 7.12.2 BioServUK Business Overview
  70. 7.12.3 BioServUK Recombinant Protein Service Revenue and Gross Margin (2021-2026)
  71. 7.12.4 BioServUK Recombinant Protein Service Product Portfolio
  72. 7.12.5 BioServUK Recent Developments
  73. 7.13 Elabscienc
  74. 7.13.1 Elabscienc Company Information
  75. 7.13.2 Elabscienc Business Overview
  76. 7.13.3 Elabscienc Recombinant Protein Service Revenue and Gross Margin (2021-2026)
  77. 7.13.4 Elabscienc Recombinant Protein Service Product Portfolio
  78. 7.13.5 Elabscienc Recent Developments
  79. 7.14 Jubilant Biosys
  80. 7.14.1 Jubilant Biosys Company Information
  81. 7.14.2 Jubilant Biosys Business Overview
  82. 7.14.3 Jubilant Biosys Recombinant Protein Service Revenue and Gross Margin (2021-2026)
  83. 7.14.4 Jubilant Biosys Recombinant Protein Service Product Portfolio
  84. 7.14.5 Jubilant Biosys Recent Developments
8 North America
  1. 8.1 North America Recombinant Protein Service Revenue (2021-2032)
  2. 8.2 North America Recombinant Protein Service Revenue by Type (2021-2032)
  3. 8.2.1 North America Recombinant Protein Service Revenue by Type (2021-2026)
  4. 8.2.2 North America Recombinant Protein Service Revenue by Type (2027-2032)
  5. 8.3 North America Recombinant Protein Service Revenue Share by Type (2021-2032)
  6. 8.4 North America Recombinant Protein Service Revenue by Application (2021-2032)
  7. 8.4.1 North America Recombinant Protein Service Revenue by Application (2021-2026)
  8. 8.4.2 North America Recombinant Protein Service Revenue by Application (2027-2032)
  9. 8.5 North America Recombinant Protein Service Revenue Share by Application (2021-2032)
  10. 8.6 North America Recombinant Protein Service Revenue by Country
  11. 8.6.1 North America Recombinant Protein Service Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Recombinant Protein Service Revenue by Country (2021-2026)
  13. 8.6.3 North America Recombinant Protein Service Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe Recombinant Protein Service Revenue (2021-2032)
  2. 9.2 Europe Recombinant Protein Service Revenue by Type (2021-2032)
  3. 9.2.1 Europe Recombinant Protein Service Revenue by Type (2021-2026)
  4. 9.2.2 Europe Recombinant Protein Service Revenue by Type (2027-2032)
  5. 9.3 Europe Recombinant Protein Service Revenue Share by Type (2021-2032)
  6. 9.4 Europe Recombinant Protein Service Revenue by Application (2021-2032)
  7. 9.4.1 Europe Recombinant Protein Service Revenue by Application (2021-2026)
  8. 9.4.2 Europe Recombinant Protein Service Revenue by Application (2027-2032)
  9. 9.5 Europe Recombinant Protein Service Revenue Share by Application (2021-2032)
  10. 9.6 Europe Recombinant Protein Service Revenue by Country
  11. 9.6.1 Europe Recombinant Protein Service Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Recombinant Protein Service Revenue by Country (2021-2026)
  13. 9.6.3 Europe Recombinant Protein Service Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China Recombinant Protein Service Revenue (2021-2032)
  2. 10.2 China Recombinant Protein Service Revenue by Type (2021-2032)
  3. 10.2.1 China Recombinant Protein Service Revenue by Type (2021-2026)
  4. 10.2.2 China Recombinant Protein Service Revenue by Type (2027-2032)
  5. 10.3 China Recombinant Protein Service Revenue Share by Type (2021-2032)
  6. 10.4 China Recombinant Protein Service Revenue by Application (2021-2032)
  7. 10.4.1 China Recombinant Protein Service Revenue by Application (2021-2026)
  8. 10.4.2 China Recombinant Protein Service Revenue by Application (2027-2032)
  9. 10.5 China Recombinant Protein Service Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Recombinant Protein Service Revenue (2021-2032)
  2. 11.2 Asia Recombinant Protein Service Revenue by Type (2021-2032)
  3. 11.2.1 Asia Recombinant Protein Service Revenue by Type (2021-2026)
  4. 11.2.2 Asia Recombinant Protein Service Revenue by Type (2027-2032)
  5. 11.3 Asia Recombinant Protein Service Revenue Share by Type (2021-2032)
  6. 11.4 Asia Recombinant Protein Service Revenue by Application (2021-2032)
  7. 11.4.1 Asia Recombinant Protein Service Revenue by Application (2021-2026)
  8. 11.4.2 Asia Recombinant Protein Service Revenue by Application (2027-2032)
  9. 11.5 Asia Recombinant Protein Service Revenue Share by Application (2021-2032)
  10. 11.6 Asia Recombinant Protein Service Revenue by Country
  11. 11.6.1 Asia Recombinant Protein Service Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Recombinant Protein Service Revenue by Country (2021-2026)
  13. 11.6.3 Asia Recombinant Protein Service Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Recombinant Protein Service Revenue (2021-2032)
  2. 12.2 SAMEA Recombinant Protein Service Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Recombinant Protein Service Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Recombinant Protein Service Revenue by Type (2027-2032)
  5. 12.3 SAMEA Recombinant Protein Service Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Recombinant Protein Service Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Recombinant Protein Service Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Recombinant Protein Service Revenue by Application (2027-2032)
  9. 12.5 SAMEA Recombinant Protein Service Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Recombinant Protein Service Revenue by Country
  11. 12.6.1 SAMEA Recombinant Protein Service Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Recombinant Protein Service Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Recombinant Protein Service Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst